renin inhibitors (GlaxoSmithKline)

N/A

Report date: 2025/03/20 09:58:07
NME

Base Information

Drug Namerenin inhibitors (GlaxoSmithKline)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRenin inhibitors
TargetsRenin
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A